Carla Shoff

Aug 5, 2024 | jamanetwork.com | Christopher Jones |Carla Shoff |Carlos Blanco |Jan L. Losby

Key PointsQuestion  During the 12 months after a nonfatal drug overdose, what percentage of Medicare beneficiaries receive medications for opioid use disorder (MOUD), naloxone, or behavioral health services, what percentage have a subsequent nonfatal or fatal drug overdose, and how does receipt of these services affect fatal drug overdose risk?

Jul 12, 2024 | jamanetwork.com | Emily Harris |Christopher Jones |Carla Shoff |Carlos Blanco

Few Medicare Beneficiaries Receive Needed Opioid Use Disorder Meds Overdose, Behavioral Health Services, and MOUD After a Nonfatal Overdose Christopher M. Jones, PharmD, DrPH; Carla Shoff, PhD; Carlos Blanco, MD, PhD; Jan L. Losby, PhD, MSW; Shari M. Ling, MD; Wilson M.

Mar 29, 2023 | jamanetwork.com | Christopher Jones |Carla Shoff |Carlos Blanco |Jan L. Losby

Key PointsQuestion  Were new federal authorities to expand telehealth use for substance use disorder treatment and to facilitate provision of medications for opioid use disorder (MOUD) during the COVID-19 pandemic associated with a lower risk for fatal drug overdose among Medicare beneficiaries initiating a new episode of opioid use disorder (OUD)–related care?

Mar 29, 2023 | jamanetwork.com | Christopher Jones |Carla Shoff |Carlos Blanco |Jan L. Losby

Key PointsQuestion  Were new federal authorities to expand telehealth use for substance use disorder treatment and to facilitate provision of medications for opioid use disorder (MOUD) during the COVID-19 pandemic associated with a lower risk for fatal drug overdose among Medicare beneficiaries initiating a new episode of opioid use disorder (OUD)–related care?